Europe Smart Biopsy Market Size & Share Report 2019-2025

Europe Smart Biopsy Market By Application (Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others) By Country, Industry Analysis and Forecast, 2019 - 2025

Published Date: November-2019 | Number of Pages: 90 | Format: PDF | Report ID: KBV-12114

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Europe Smart Biopsy Market

Market Report Description

The Europe Smart Biopsy Market would witness market growth of 4.92% CAGR during the forecast period (2019-2025). Novel non-invasive tools have been developed which allow the characterization of cancer tissue in real-time. These tools are referred to as smart biopsies and have already been used in several hospitals to speed up cancer diagnosis. Bringing these projects from the laboratory bench into a medical setting will make cancer diagnosis faster and cheaper, leading to earlier access to the right treatment for patients and providing a clear opportunity for players to get them there.

One of the challenges of carrying out surgery on a brain tumor is that it is necessary to prevent any damage to the blood vessels. The reason being, such damages can cause bleeding and even prove to be fatal. Through advancements in brain imaging surgeons can navigate their method accurately— this has made surgical procedures much safer. With the development of a new high-tech biopsy needle that carries a tiny imaging probe inside to help guide the way, biopsy procedures are now expected to become smoother.

In addition, growing awareness of various diseases, particularly among women with an unhealthy lifestyle, is expected to boost the demand for smart biopsy devices. As per the National Center for Biotechnology Information (NCBI), one of the most common cancers among women in Europe is cervical cancer, primarily among women over the age of 45.

Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: Smart Biopsy Market in Europe is expected to register a CAGR of 4.92% during the forecast period (2019-2025)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.

Scope of the Smart Biopsy Market Analysis

Market Segmentation:

By Application

  • Breast cancer
  • Skin cancer
  • Liver cancer
  • Prostate cancer and
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Danaher Corporation
  • Argon Medical Devices, Inc.
  • Cardinal Health, Inc.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • B. Braun Melsungen AG
  • Cook Medical, Inc. (Cook Group)
  • Medtronic Plc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Smart Biopsy Market Related Reports:

Global Market

North America Market

Asia Pacific Market

LAMEA Market

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities